Cargando…
Multi‐cohort analysis identifies somatic NTRK mutations as a biomarker for immune checkpoint inhibitor use in cutaneous melanoma
Autores principales: | Yan, Junya, Deng, Long, Yu, Jiayi, Wu, Xiaowen, Wang, Shaoyu, Cang, Shundong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10660794/ https://www.ncbi.nlm.nih.gov/pubmed/37987157 http://dx.doi.org/10.1002/ctm2.1478 |
Ejemplares similares
-
Prognostic Role of Tumor Mutation Burden Combined With Immune Infiltrates in Skin Cutaneous Melanoma Based on Multi-Omics Analysis
por: Yan, Junya, et al.
Publicado: (2020) -
An Immune-Related Gene Pair Index Predicts Clinical Response and Survival Outcome of Immune Checkpoint Inhibitors in Melanoma
por: Yan, Junya, et al.
Publicado: (2022) -
Somatic chromosomal engineering identifies BCAN-NTRK1 as a potent glioma driver and therapeutic target
por: Cook, Peter J., et al.
Publicado: (2017) -
Identifying patients with NTRK fusion cancer
por: Solomon, J P, et al.
Publicado: (2019) -
Utility of urinary biomarkers in primary haematuria: Systematic review and meta‐analysis
por: Soputro, Nicolas Adrianto, et al.
Publicado: (2022)